皮肤与化妆品研究室，环境和职业性皮肤病学科为同济大学附属皮肤病医院重点学科，建设过敏性皮肤病诊疗中心。现为中华医学会皮肤性病学分会特应性皮炎研究中心、荨麻疹研究中心，中国中西医结合学会皮肤性病专委会湿疹皮炎研究基地，国家药品监督管理局（NMPA）首批国家化妆品不良反应监测评价基地、NMPA化妆品注册和备案检验机构、NMPA监测评价重点实验室联合单位、上海市化妆品不良反应监测中心。

作为项目负责人，承担国家自然科学基金、国家药监局标准标题、上海市科委、申康中心、上海市卫健委等课题十余项

 PD-1调控组织驻留型记忆T细胞抑制特应性皮炎复发性炎症的作用机制研究，国家自然科学基金，主持

 重症医学科运行管理模式探索研究，上海申康医院发展中心管理研究项目委托项目，主持

 化妆品不良反应判断标准研究，国家药品监督管理局药品评价中心，主持

 免疫分型在AD精准诊疗中的应用研究，上海市科委“科技创新行动计划”医学创新研究专项，主持

 优秀学科带头人，上海市公共卫生优秀人才培养计划，上海市卫生健康委员会，主持

 LIGHT/HVEM信号调控T细胞活化在特应性皮炎发病中的作用及机制研究，国家自然科学基金，主持

 银屑病早期诊断及疗效评价非创方法的建立，上海申康医院发展中心专科疾病临床“五新”转化项目，主持

 皮肤生理参数对湿疹患者病情评估及疗效评价研究，上海市科委医学引导项目，主持

 肿瘤坏死因子超家族分子LIGHT在银屑病中的作用及信号通路研究，上海市卫计委面上项目，主持

 LIGHT与其受体在银屑病皮损中的表达及致病机理的研究，上海市卫生局青年项目，主持

Funding & Talent Program

 “Study on the mechanism of PD-1 regulating tissue resident memory T cell in atopic dermatitis recurrence inflammation suppression” from foundation of National Natural Science Foundation of China, China; Project Leader

 Exploratory Research on the Operation and Management Model of the Department of Critical Care Medicine, Entrusted Project of the Management Research Project of Shanghai Shenkang Hospital Development Center; Project Leader

  “Criteria for Adverse Reactions toCosmetics” from foundation of China National Drug Administration DrugEvaluation Center, China; Project Leader

 “Atopic dermatitis endotypes and application for targeted therapeutics.” from foundation of Shanghai Science and Technology Commission, China; Project Leader

 Excellent Academic Leader, Shanghai public health talents training plan, Shanghai Municipal Health Commission, China; Project Leader

 “LIGHT / HVEM costimulating T cell in the pathogenesis of atopic dermatitis” from foundation of National Natural Science Foundation of China, China; Project Leader

 “Non-invasive measurement method for evaluation of psoriasis diagnosis and clinical effect” from foundation of Shanghai Hospital Development Center, China; Project Leader

 “Evaluation of skin severity and treatment efficacy by physiological parameters in eczema patients” from foundation of Shanghai Science and Technology Commission, China; Project Leader

 “The effect and related mechanisms of LIGHT (TNFSF14) in the pathogenesis of psoriasis” from foundation of Shanghai Municipal Commission of Health and Family Planning, China; Project Leader

 “The optimization in the management of atopic eczema” from foundation of Shanghai Science and Technology Commission, China; Senior Researcher

 “The expression and pathogenicity of LIGHT and its receptor in psoriasis” from Shanghai Municipal Commission of Health and Family Planning, China; Project Leader

论文 Publications

 Chunjiao Zheng, Ting Cao, Cheng bin Ye, Ying Zou＃. Neutrophilrecruitment by CD4 tissue-resident memory T cells induces chronic recurrentinflammation in atopic dermatitis. Clin Immunol. 2023;256:109805. (通讯作者)

 Jingwen Yang, Fei Tan, Haimei Kong, Ying Zou＃, Yimei Tan＃. The roleand safety of UVA and UVB in UV-induced skin erythema. Front Med (Lausanne).2023 Jun 27;10:1163697. (通讯作者)

 Ting Cao, Xuyang Zhou, Xingbiao Wu, Ying Zou＃. Cutaneousimmune-related adverse events to immune checkpoint inhibitors: from underlyingimmunological mechanisms to multi-omics prediction. Front Immunol. 2023 Jun22;14:1207544.(通讯作者)

 Chunjiao Zheng, Ying Zou＃. Allergen Sensitization in Patients withSkin Diseases in Shanghai, China. J Asthma Allergy. 2023 Mar 20;16:305-313. (通讯作者)

 Chunjiao Zheng, Yuling Shi＃, Ying Zou＃. T cell co-stimulatory andco-inhibitory pathways in atopic dermatitis. Front Immunol. 2023 Mar13;14:1081999. (通讯作者)

 Cheng bin Ye, Hui jing Gu, Meng yi Li, Ren jie Chen, Xiang Xiao＃, YingZou＃. Air Pollution and Weather Conditions Are Associated with DailyOutpatient Visits of Atopic Dermatitis in Shanghai, China. Dermatology. 2022,238(5), 939-949. (通讯作者)

 Bingjie Li,Ying Cheng,Yimei Tan, Fudi Wang,Weiyi Hu, Xuemin Wang, Wei Liu, JeanKrutmann, Sijia Wang＃, Ying Zou＃. Analysis of factors influencing skin reactions to sunscreens,skin whitening products, and deodorants: results from a large-scale patch testdataset in China. J Cosmet Dermatol. 2022 Sep;21(9):3986-3992. (通讯作者)

 Guobiao Fan, ChangingJiang, Peilan Wu, Ying Zou＃, Yimei Tan＃.Evaluation and Detection of Early Nail Damage Caused byNail Enamel. 2022 Aug;21(8):3464-3468.(通讯作者)

 Bingjie Li,Ying Cheng,Yimei Tan, Fudi Wang,Weiyi Hu, Xuemin Wang, Wei Liu, JeanKrutmann, Sijia Wang＃, Ying Zou＃. Analysis of factors influencing patch test reactions: Resultsfrom a large-scale population-based study in Chinese. J Cosmet Dermatol. 2022May;21(5):2183-2188. (通讯作者)

 Chengwen Fei, Yafei Xu, Ting Cao, Wencai Jiang, Ying Zou＃, Howard Maibach. Effect of scratchingand friction on human skin in vivo. Skin Res Technol. 2021Nov;27(6):1049-1056. (通讯作者)

 Yanrui Gao, Yingfang Li, Yimei Tan, Wei Liu, Sara Ouaddi, John McCoy, MajaKovacevic, Mirna Situm,Andrija Stanimirovic,Marissa Li,Carlos Wambier,Andy Goren, Ying Zou＃. Novelcannabidiol aspartame combination treatment (JW-100) significantly reduces ISGAscore in atopic dermatitis: Results from a randomized double-blinded placebo-controlledinterventional study. J Cosmet Dermatol. 2022 Apr;21(4):1647-1650. (通讯作者)

 Huijing Gu, Li Peng,Wencai Jiang, Yimei Tan, Guojiang Zhou, HaidongKan, Renjie Chen, Ying Zou＃. Impactof solar ultraviolet radiation on daily outpatient visits of atopic dermatitisin Shanghai, China. Environmental Science and Pollution Research, 2021,28(14),18081-18088. (通讯作者)

 Ting Cao, Yanrui Gao, Linfeng Li＃, YingZou＃, Howard Maibach. Change in China Patch Testing Practices over 13 Years:Updated Cross-sectional Survey & Possible International Implications. ContactDermatitis, 2021,84:159–165. (通讯作者)

 Yimei Tan＃,  Fudi Wang, Guobiao Fan,Y. Zheng, B. Li, N. Li, Y. Liu, X. Wang, Wei Liu, J. Krutmann, Ying Zou＃, Sijia Wang＃. Identification of factorsassociated with minimal erythema dose variations in a large-scale populationstudy of 22146subjects. J Eur Acad Dermatol Venereol, 2020,34(7):1595-1600 (通讯作者)

 Ou Qin,Ying Cheng,Weiyi Hu,Hong Zhou,Yimei Tan,Shuting Guo,Xin Jin,LinTao,Lei Du,Jieheng Wang,Xuemin Wang,YingZou＃,Howard Maibach. Patch test in Chinese in Shanghai with cosmetic allergy tocosmetic series and products. J Cosmet Dermatol, 2020,19(8):2086-2092 (通讯作者)

 Ying Zou, Howard I. Maibach. Dermal-epidermal separation methods: researchimplications. Arch Dermatol Res, 2018, 310:1-9

 Ying Zou, Anna Celli, Hanjiang Zhu, AkramElmahdy, Yachao Cao, Xiaoying Hui, Howard Maibach. Confocal laser scanningmicroscopy to estimate nanoparticles’ human skin penetration in vitro. Int JNanomed, 2017, 12: 8035–8041 

 Ying Zou, Minggai Ge, Xuemin Wang.Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cellcarcinoma cell growth in vitro and in vivo. Biochem Biophys Res Commun, 2017,490(2): 385-392

 Ying Zou, Guoibao Fan, Xuemin Wang.Pre-clinical assessment of A-674563 as an anti-melanoma agent. Biochem Biophys Res Commun, 2016, 477(1):1-8

 Ying Zou, Xuemin Wang, Guoibao Fan. Improvement of the facial evenness of leave-onskincare products by a modified application method in Chinese women. Inter JCosmetic Sci, 2015, 37: 229-235

 Ying Zou, Xuemin Wang. Patch testing practices and perception of Chinesedermatologists: Results of a Cross-Sectional Survey. Contact Dermatitis, 2012, 66(4):205-209

学术论著 Monographs

 英文专著《Percutaneous Absorption, Fifth Edition》，参编，章节“Dermal-EpidermalSeparation Methods: Research Implications”，2021/07，CRC Press

 英文专著《Methods in Molecular Biology》，参编，“EpidermalCells: Methods and Protocols, Fourth Edition”，2019/12，Springer

 英文专著《Contact Dermatitis, Sixth Editioin》，参编，章节“TheChinese Baseline Series”，2019/10，Springer

 英文专著《Textbook of Aging Skin, Second Editioin》，参编，章节“Pigmentationin Ethnic Groups”，2016/04，Springer

 英文专著《The Vulva, Physiology and Clinical Management, Second Editioin》，参编，章节“Vulva Ethnic Differences: An Overview”，2017/03，CRC Press

 《皮肤病与性病学（汉英对照）》参编，人民卫生出版社，2022/12

 《中药经皮给药与功效性化妆品》，副主编，中国医药科技出版社，2019/05

指南制定 Guideline

 抗皮肤老化类护肤品在面部年轻化中的应用专家共识（2022）

 皮肤微生态与皮肤健康专家共识(第2部分:皮肤微生态与皮肤疾病)

 保湿润肤类产品应用指导专家共识（2023版）

 湿疹皮炎类皮肤病中西医结合药物治疗专家共识

 中国慢性诱导性荨麻疹诊治专家共识（2023）

 中国荨麻疹诊疗指南（2022版）

 皮肤微生态与皮肤健康专家共识(第1部分:皮肤微生态概述)

 皮肤疾病超声检查指南(2022版) 

 抗IgE疗法——奥马珠单抗治疗慢性荨麻疹专家共识

 特应性皮炎瘙痒管理专家共识

 中国手部湿疹诊疗专家共识（2021版）

 斑贴试验临床应用专家共识（2020修订版）

 中国特应性皮炎诊疗指南（2020版）

 中国荨麻疹诊疗指南（2018版）

学术任职：

 中国中西医结合学会皮肤性病分会委员、特应性皮炎学组副组长
 中国医师协会皮肤科医师分会第六届变态反应疾病学组 委员
 国家药品监督管理局化妆品监测评价重点实验室学术委员会 委员
 中华医学会皮肤性病学分会荨麻疹研究中心 委员

 中华医学会皮肤性病学分会特应性皮炎研究中心 委员

 国家药监局化妆品风险监测与科普专家组成员

 欧洲变态反应与临床免疫学会（EAACI） 成员
 欧洲接触性皮炎学会（ESCD） 成员

 美国接触性皮炎学会（ACDS） 成员

Academic Participation

 Vice Chairman of Youth committee, Dermatological Medicine Research Committee, China Association of Traditional Chinese Medicine
 Vice-leader, Atopic Dermatitis Group, Dermatovenerology Committee, Chinese Association of Integrative medicine
 Youth Committee Member, Prevention and Control committee for Dermatovenerology, Chinese Preventive Medicine Association
 PI member, Atopic Dermatitis Research Center, Chinese Society of Dermatology
 PI member, Eczema & Dermatitis Research Center, Dermatovenerology Committee, Chinese Association of Integrative medicine
 PI member, Urticaria Research Center, Chinese Society of Dermatology
 Member, European Academy of Allergy and Clinical Immunology（EAACI）
 Member, Society for Investigative Dermatology (SID)
 Member, American Contact Dermatitis Society (ACDS)
 Member, European Society of Contact Dermatitis (ESCD)
 Member, The 5th Professional Committee of China Illuminating Engineering Association
 Member, Allergology Academic Board, Dermatology Branch, Shanghai Medical Association
 Member, the 9th Immunology Academic Board, Dermatology Branch, Shanghai Medical Association
 Member, China Dermatologist Association